AAP
CRMD icon

Arax Advisory Partners’s CorMedix CRMD Stock Holding History

Arax Advisory Partners’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.69K Buy
+980
New +$7.74K ﹤0.01% 4443
2026
Q1 		– Sell
-129
Closed -$1.5K – 3906
2025
Q4 		$1.5K Sell
129
-283
-69% -$3.13K ﹤0.01% 3364
2025
Q3 		$4.79K Buy
+412
New +$4.98K ﹤0.01% 2885
2024
Q4 		– Sell
-31
Closed -$251 – 2498
2024
Q3 		$251 Hold
31
– – ﹤0.01% 2495
2024
Q2 		$135 Buy
+31
New +$157 ﹤0.01% 2470

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Arax Advisory Partners's CRMD Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in CorMedix (CRMD) in Q2 2026: 980 shares worth $7.69K. The stake represents ﹤0.01% of the portfolio and ranks #4443 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in CRMD as recently as Q4 2025.

Arax Advisory Partners first reported a position in CRMD in Q2 2024 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Arax Advisory Partners held 980 shares of CorMedix worth $7.69K as of Q2 2026.
  • CorMedix was a new Arax Advisory Partners position in Q2 2026.
  • CorMedix made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4443 holding.
  • Arax Advisory Partners first reported a position in CorMedix in Q2 2024 and has held it in 5 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.